Pfizer Inc. (PFE)
29.79
-0.24
(-0.80%)
USD |
NYSE |
Oct 26, 16:00
29.79
0.00 (0.00%)
Pre-Market: 05:14
Pfizer Price to Book Value : 1.993 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.993 |
| October 23, 2026 | 2.009 |
| October 22, 2026 | 2.035 |
| October 21, 2026 | 1.997 |
| October 20, 2026 | 2.014 |
| October 19, 2026 | 1.970 |
| October 16, 2026 | 1.979 |
| October 15, 2026 | 1.970 |
| October 14, 2026 | 1.954 |
| October 13, 2026 | 1.898 |
| October 12, 2026 | 1.900 |
| October 09, 2026 | 1.892 |
| October 08, 2026 | 1.861 |
| October 07, 2026 | 1.873 |
| October 06, 2026 | 1.840 |
| October 05, 2026 | 1.834 |
| October 02, 2026 | 1.860 |
| October 01, 2026 | 1.881 |
| September 30, 2026 | 1.908 |
| September 29, 2026 | 1.921 |
| September 28, 2026 | 1.921 |
| September 25, 2026 | 1.918 |
| September 24, 2026 | 1.901 |
| September 23, 2026 | 1.885 |
| September 22, 2026 | 1.868 |
| Date | Value |
|---|---|
| September 21, 2026 | 1.856 |
| September 18, 2026 | 1.850 |
| September 17, 2026 | 1.849 |
| September 16, 2026 | 1.837 |
| September 15, 2026 | 1.843 |
| September 14, 2026 | 1.854 |
| September 11, 2026 | 1.854 |
| September 10, 2026 | 1.850 |
| September 09, 2026 | 1.858 |
| September 08, 2026 | 1.859 |
| September 04, 2026 | 1.903 |
| September 03, 2026 | 1.927 |
| September 02, 2026 | 1.941 |
| September 01, 2026 | 1.910 |
| August 31, 2026 | 1.904 |
| August 28, 2026 | 1.870 |
| August 27, 2026 | 1.874 |
| August 26, 2026 | 1.893 |
| August 25, 2026 | 1.911 |
| August 24, 2026 | 1.871 |
| August 21, 2026 | 1.878 |
| August 20, 2026 | 1.859 |
| August 19, 2026 | 1.889 |
| August 18, 2026 | 1.823 |
| August 17, 2026 | 1.798 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.862 |
| Eli Lilly & Co. | 35.55 |
| Merck & Co., Inc. | 8.278 |
| Bristol Myers Squibb Co. | 5.640 |
| Viatris, Inc. | 1.482 |
Price to Book Value Related Metrics
| PE Ratio | 39.45 |
| PS Ratio | 2.669 |
| Price to Free Cash Flow | 15.48 |
| Price | 29.79 |
| Earnings Yield | 2.54% |
| Market Cap | 169.77B |
| Operating PE Ratio | 10.04 |
| Normalized PE Ratio | 12.30 |